Elicio Therapeutics, Inc.
ELTX · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Adams Julian: Form 4
Insider disclosure · Filed · Report period 31 Aug 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ELTX · 28657F103 - Common Stock, par value $0.01 per share
Company details and SEC sources
CIK 0001601485 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ELTX on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 451 D Street, 5 Th Floor, Boston, MA, 02210
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Angion Biomedica Corp. (to 30 May 2023)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields